NCT03285490 2021-03-10A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)Almirall, S.A.Phase 3 Completed351 enrolled 16 charts